Ads
related to: PfizerExpertise On Every Level To Craft Science & Technology Solutions In Life Science. Solving Problems In Life Science By Collaborating With the Global Scientific Community.
- Sign In
Sigma® Life Science
View contract pricing, get quotes
- Analytical/Chromatography
Browse our Analytical Reagents,
Standards, Microbiology and more.
- Sigma® Life Science
Cell culture, antibodies
and more biological products
- Order Center
Build a Shopping Cart, View Orders
Access ordering instructions
- Classic Lab Chemicals
High-quality laboratory reagents.
Solvents, salts, acids, bases
- Register an Account
Get product updates, special offers
Save favorites & shopping lists
- Sign In
A global leader in pharmaceutical contract development and manufacturing (CDMO). An altogether different CDMO with over 40 years of experience.
Search results
Pfizer prioritizes the health and well-being of people and the planet to deliver breakthroughs around the world in a responsible way. Learn more in Pfizer’s 2023 Impact Report Behind the Science Feature
- Careers
Depending on the customs and laws of a specific country,...
- Products
Programs & Initiatives Pfizer's Multicultural Health Equity...
- Contact Us
Pfizer Inc. 66 Hudson Boulevard East New York, NY 10001-2192...
- Newsroom
Pfizer surveyed adults in 10 countries across the Global...
- Executives
Terramycin also marks the beginning of the Pfizer...
- Updates and Statements
10.25.2023 Vaccines Pfizer’s PENBRAYA™ Receives...
- About
Pfizer purchases a nearby vacant ice plant, and employees...
- Careers
Pfizer Inc. (/ ˈ f aɪ z ər / FY-zər) is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
Dec 11, 2020 · COMIRNATY is the first COVID-19 vaccine to be granted approval by the FDA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210823005499/en/ The vaccine has been available in the U.S. under Emergency Use Authorization (EUA) since December 11, 2020 (as the Pfizer-BioNTech COVID-19 Vaccine).
Pfizer Inc. and BioNTech SE announced today they have begun an evaluation of the safety and immunogenicity of a third dose of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) to understand the effect of a booster on immunity against COVID-19 caused by the circulating and potential newly emerging SARS-CoV-2 variants.
Aug 23, 2021 · August 23, 2021. Español. Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be...
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing.
At Pfizer our biotechnology is our foundation. With 25,000 clinical researchers testing everyday, pharmaceutical development and innovation are our focus. Learn more.
Ad
related to: PfizerExpertise On Every Level To Craft Science & Technology Solutions In Life Science. Solving Problems In Life Science By Collaborating With the Global Scientific Community.
Services:
